ClinicalTrials.gov
ClinicalTrials.gov Menu

Chart Review of Treatments Received by Patients Diagnosed With Soft Tissue Sarcoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00322855
Recruitment Status : Terminated (Low accrual)
First Posted : May 8, 2006
Results First Posted : July 9, 2015
Last Update Posted : July 31, 2015
Sponsor:
Information provided by (Responsible Party):
New Mexico Cancer Care Alliance

Brief Summary:
To review the outcome of patients with soft tissue sarcoma treated with chemotherapy from 2004 and 2005.

Condition or disease
Sarcoma

Detailed Description:
Chart review of patients with soft tissue sarcoma treated with chemotherapy from 2004 and 2005 to determine outcome

Study Type : Observational
Actual Enrollment : 1 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Chart Review of Treatments Received by Patients Diagnosed With Soft Tissue Sarcoma
Study Start Date : August 2005
Actual Primary Completion Date : July 2007
Actual Study Completion Date : August 2007

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort
Chart Review
patients diagnosed with soft tissue sarcoma



Primary Outcome Measures :
  1. To Review the Outcome of Patients With Soft Tissue Sarcoma Treated With Chemotherapy From 2004 and 2005 [ Time Frame: up to one year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with soft tissue sarcoma treated with chemotherapy form 2004 and 2005.
Criteria

Inclusion Criteria:

  • Patients diagnosed with soft tissue sarcoma treated with chemotherapy form 2004 and 2005.

Exclusion Criteria:

  • Not Specified

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00322855


Locations
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87131
Sponsors and Collaborators
New Mexico Cancer Care Alliance
Investigators
Principal Investigator: Aroop Mangalik, MD University of New Mexico

Responsible Party: New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier: NCT00322855     History of Changes
Other Study ID Numbers: INST 0517C
First Posted: May 8, 2006    Key Record Dates
Results First Posted: July 9, 2015
Last Update Posted: July 31, 2015
Last Verified: July 2015

Additional relevant MeSH terms:
Sarcoma
Neoplasms, Connective and Soft Tissue
Neoplasms by Histologic Type
Neoplasms